Two unusual sites of metastases of esophageal adenocarcinoma.

Afshin Amini, Elliot Koury, Zahra Vaezi, Ann Leathersich, Sajid Zafar, Elie Chahla

Abstract readCase Reports

In one paragraph

Article in Gastroenterology and hepatology from bed to bench, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Afshin AminiDepartment of Medicine, St. Luke's Hospital, Chesterfield, MO, USA.

Elliot KouryDepartment of Medicine, St. Luke's Hospital, Chesterfield, MO, USA.

Zahra VaeziDepartment of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.

Ann LeathersichDepartment of Pathology, St. Luke's Hospital, Chesterfield, MO, USA.

Sajid ZafarDivision of Gastroenterology and Hepatology, Department of Medicine, St. Luke's Hospital, Chesterfield, MO, USA.

Elie ChahlaDepartment of Medicine, St. Luke's Hospital, Chesterfield, MO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most common sites of metastasis for esophageal cancers include the liver, lungs, and bones. We report a rare case of esophageal adenocarcinoma with metastasis to the subcutaneous perianal region as well as to the small bowel. Physicians should consider the possibility of metastasis in a patient with esophageal adenocarcinoma even after the onset of remission. It is essential to examine these patients and maintain a high index of suspicion for possible metastases. Early recognition helps in the accurate staging of the disease and enables the initiation of life-prolonging therapy and achieving meaningful palliation.

Indexed as

Esophageal adenocarcinomaMetastasesUnusual sites

Identifiers

PMID32308943

PMCPMC7149818

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.